Cetirizine/pseudoephedrine
| Combination of | |
|---|---|
| Cetirizine | Antihistamine |
| Pseudoephedrine | Decongestant |
| Clinical data | |
| Trade names | Zyrtec-D, Aller-Tec D, Cetiri-D, Cirrus, |
| AHFS/Drugs.com | Multum Consumer Information |
| Routes of administration | By mouth |
Cetirizine/pseudoephedrine (Zyrtec-D) is an
fixed-dose combination drug containing 5 mg cetirizine hydrochloride and 120 mg pseudoephedrine hydrochloride for symptoms related to seasonal allergic rhinitis.[1][2][3] Cetirizine/pseudoephedrine gained approval from the U.S. Food and Drug Administration in 2001 as a prescription drug and became over-the-counter (OTC) in 2007.[4]
References
- ^ "ZYRTEC-D ALLERGY PLUS CONGESTION- cetirizine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release". DailyMed. 25 April 2022. Retrieved 28 September 2022.
- PMID 19203562.
- PMID 9299654.
- ^ "FDA approves J&J's non-prescription Zyrtec-D". PharmaTimes. 12 November 2007. Retrieved 12 December 2022.